Overview
If you are looking for an opportunity to stay informed on the latest developments in clinical trial disclosure and data transparency from the comfort of your own home or office, the upcoming Clinical Trial Disclosure and Data Transparency Virtual Conference is a meeting you won't want to miss. This virtual conference builds on the success of prior editions, leveraging insights from regulatory bodies and industry experts from around the world.
By attending, you will gain essential and timely information on global clinical trial disclosure, data sharing for secondary research, and the EU Clinical Trial Information System (CTIS), all from the convenience of your computer or mobile device. For those in R&D management, Clinical Development, Out Licensing and Merger & Acquisitions: understanding the requirements and rules around CCI disclosure and protection under EU CTR is key to mitigate potential risks relating to portfolio assets.
With a focus on transparency while protecting personal data and commercially confidential information, this conference is a must-attend for anyone involved in clinical trials.
Featured
Want to learn more about DIA Global Clinical Trial Disclosure and Data Transparency Conference ? You've come to the right site!
EU CTR: Transparency, PPD, and CCI Requirements
Hear about the strategic view of achieving transparency and the utility of data in CTIS while ensuring EU remains attractive for clinical trials by ensuring sponsors commercially confidential information is protected.
CTIS/CTR: 1 Year into its full Application
What have been the experiences with the CTIS and CTR after 1 year of its application, from different stakeholders: from sponsors to regulators and national competent authorities?
Program Committee
-
Merete Joergensen, MBA, MSc Clinical Disclosure and Transparency Expert
Merete-J Consulting, Denmark -
Scott Feiner Senior Manager, Trial Disclosure
AbbVie, United States -
Robert Paarlberg, MS Principal
Paarlberg & Associates LLC, United States -
Matthias Zerm, PhD Lead Expert, Clinical Trial Disclosure and R&D Processes
Merz Therapeutics GmbH, Germany -
Thomas Schindler, PhD Director Global Regulatory Affairs - Regulatory Operations
BioNTech SE, Germany -
Joyce Swart Director, Clinical Trial Disclosure
Alcon Research, LLC, United States -
Lora Killian, MBA Clinical Trial Transparency and Disclosure Lead
Pfizer, United States -
Ruediger Pankow, DrSc Clinical Trial Regulatory Consultant | CTIS SME
Independent Consultant, Germany
Have an account?